Streetbeat News

Products Services

CC

Chemours reported better-than-expected earnings and revenues for Q3, with record sales in its Thermal & Specialized Solutions division, driven by Opteon refrigerants.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

GAUZ

REFR

CEOs of Gauzy and Research Frontiers discuss their partnership and Ferrari's use of SPD technology in a Benzinga interview.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

OM

Outset Medical, Inc. (Nasdaq: OM) reported its financial results for the third quarter of 2024, highlighting its innovative technology aimed at reducing dialysis costs and complexity.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

KROS

Keros Therapeutics, a clinical-stage biopharmaceutical company, reported its third quarter 2024 financial results and business highlights. The company focuses on developing therapeutics for disorders related to TGF-ß protein signaling.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

CYTK

Cytokinetics has reported its Q3 2024 financial results, highlighting the completion of the NDA submission for Aficamten to the FDA. The company plans to start new clinical trials for Omecamtiv Mecarbil and CK-586 in Q4, and advance CK-089 into human studies. Cytokinetics holds approximately $1.3 billion in cash and investments.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

PRME

Prime Medicine, Inc. (Nasdaq: PRME) will participate in upcoming investor conferences, highlighting its commitment to developing one-time curative genetic therapies.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

RVMD

Revolution Medicines has reported its third quarter 2024 financial results and provided an update on its corporate progress. A Phase 3 pivotal trial is underway for RMC-6236, targeting metastatic pancreatic ductal adenocarcinoma (PDAC), supported by a compelling clinical profile.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

TOL

Toll Brothers has opened a new 55+ community, Regency at Auburn Station, in Raleigh, North Carolina. This community offers low-maintenance luxury living with resort-style amenities, targeting the senior demographic.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

ABOS

Acumen Pharmaceuticals will participate in a fireside chat at the UBS Global Healthcare Conference on November 13, 2024. The company is focused on developing treatments for Alzheimer's disease.

Portfolio Pulse from

November 06, 2024 | 9:15 pm

GNLX

Genelux Corporation (NASDAQ: GNLX) will participate in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference, where CEO Thomas Zindrick will discuss the company's clinical-stage programs and upcoming milestones.

Portfolio Pulse from

November 06, 2024 | 9:15 pm